Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
dorsaVi Limited ( (AU:DVL) ) just unveiled an update.
DorsaVi Limited, a provider of wearable sensor and motion analysis solutions for clinical, workplace, and sports applications, focuses on delivering objective biomechanical data to support injury assessment, risk management, and performance improvement. The company operates in specialised healthcare and occupational health markets where technology-enabled movement analytics are increasingly used to inform decision-making.
For the half-year to 31 December 2025, DorsaVi reported an 8.3% fall in revenue to $764,453 and a sharply higher after-tax loss of $3.59 million, driven mainly by a significant increase in share-based payment expenses. Despite the deeper loss and the absence of dividends, cash rose to $4.95 million and net assets increased to $5.99 million, improving net tangible assets per share and indicating a strengthened balance sheet even as operating performance remains under pressure.
The most recent analyst rating on (AU:DVL) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on dorsaVi Limited stock, see the AU:DVL Stock Forecast page.
More about dorsaVi Limited
DorsaVi Limited develops and sells wearable sensor and motion analysis technologies used to assess human movement. Its products serve clinical, workplace, and sports markets that rely on objective biomechanical data for injury assessment, performance optimisation, and risk management.
Average Trading Volume: 1,457,257
Technical Sentiment Signal: Sell
Current Market Cap: A$32.77M
See more insights into DVL stock on TipRanks’ Stock Analysis page.